Tag: PARP inhibitors TNBC

January 5, 2026

Triple-Negative Breast Cancer: Modern Treatment Strategies and Ongoing Clinical Trials

Triple-negative breast cancer (TNBC) has no hormone receptors or HER2, making treatment challenging. Learn the latest therapies-immunotherapy, PARP inhibitors, ADCs-and breakthrough clinical trials changing outcomes in 2025-2026.

Health and Medicine